Source:http://linkedlifedata.com/resource/pubmed/id/19209621
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2009-2-12
|
pubmed:abstractText |
Testotoxicosis is a rare form of precocious puberty caused by a constitutively activating mutation in the luteinizing hormone receptor (LHR) gene. Symptoms include rapid virilization, accelerated growth and reduced adult height. We describe a rare association of testotoxicosis with a metaphyseal chondrodysplasia called cartilage-hair hypoplasia (CHH) and report two brothers with testotoxicosis after 4 years of treatment. The brothers had a T577I mutation in the LHR gene. One brother also presented CHH. The older brother was treated with ketoconazole, then with the aromatase inhibitor anastrozole and the anti-androgen cyproterone acetate. The younger brother received this combination as first-line therapy. Clinical improvements included reductions in growth velocity and bone maturation rate, which should result in taller adult stature. Tolerance was good. CONCLUSION: Combined treatment with anastrozole and cyproterone acetate is effective in improving the prognosis of adult height in testotoxicosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Aromatase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Cyproterone Acetate,
http://linkedlifedata.com/resource/pubmed/chemical/Nitriles,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, LH,
http://linkedlifedata.com/resource/pubmed/chemical/Triazoles,
http://linkedlifedata.com/resource/pubmed/chemical/anastrozole
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0334-018X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
995-1002
|
pubmed:meshHeading |
pubmed-meshheading:19209621-Androgen Antagonists,
pubmed-meshheading:19209621-Aromatase Inhibitors,
pubmed-meshheading:19209621-Body Height,
pubmed-meshheading:19209621-Child, Preschool,
pubmed-meshheading:19209621-Cyproterone Acetate,
pubmed-meshheading:19209621-Humans,
pubmed-meshheading:19209621-Infant,
pubmed-meshheading:19209621-Male,
pubmed-meshheading:19209621-Mutation,
pubmed-meshheading:19209621-Nitriles,
pubmed-meshheading:19209621-Puberty, Precocious,
pubmed-meshheading:19209621-Receptors, LH,
pubmed-meshheading:19209621-Treatment Outcome,
pubmed-meshheading:19209621-Triazoles
|
pubmed:year |
2008
|
pubmed:articleTitle |
Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty.
|
pubmed:affiliation |
Paediatric Endocrinology Unit, Hôpital Necker-Enfants Malades, Paris, France.
|
pubmed:publicationType |
Journal Article,
Case Reports
|